Literature DB >> 23102630

Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode.

Dalibor Karlović1, Alessandro Serretti, Saša Jevtović, Nada Vrkić, Vesna Serić, Alma Mihaljević Peleš.   

Abstract

Diagnosing major depressive disorder (MDD) continues to be based on meeting phenomenological and descriptive criteria. As of yet, there is still no non-invasive, peripheral biomarker that would allow for a certain diagnosis of MDD. The objective of this paper is to use the receiver operating characteristic (ROC) analysis to test the diagnostic value of serum concentrations of brain derived neurotrophic factor (BDNF) in diagnosing the first episode of MDD. Among 1014 patients admitted for an initial psychiatric evaluation, antidepressant naïve patients diagnosed with first episode MDD were separated into the test group. Only patients signing an informed consent form were included in the study. Using DSM-IV-TR diagnostic criteria, those patients meeting the MDD criteria (N = 122) and patients not meeting MDD or other psychiatric disorder criteria (N = 142) were differentiated. Subjects with repeated episode MDD (N = 121) and other psychiatric comorbid illnesses (N = 138) in the MDD group were excluded from the study. In the group without MDD or other psychiatric illnesses, patients with physical comorbidities (N = 59) were excluded. The serum concentration of BDNF was determined in all patients using the ELISA assay. Subjects with first episode MDD showed differences in serum BDNF concentrations (ng/mL) in comparison to the control group of patients not meeting the criteria for first episode MDD (mean ± SD; 37.5 ± 13.3 vs. 56.8 ± 6.3; t = 1.372; df = 262; p < 0.01). The ROC analysis established a discriminant diagnostic value of serum BDNF in diagnosing MDD. The area under the curve (AUC) was 0.892 with a 95% confidence level (0.826-0.939), which was statistically significant at p < 0.01. The serum BDNF had a high diagnostic sensitivity of 83.9% and a specificity of 93%. Serum BDNF concentrations appear to be a promising tool in discriminating subjects with MDD from those without MDD.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102630     DOI: 10.1016/j.jpsychires.2012.09.017

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  8 in total

Review 1.  Convergent Mechanisms Underlying Rapid Antidepressant Action.

Authors:  Panos Zanos; Scott M Thompson; Ronald S Duman; Carlos A Zarate; Todd D Gould
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

Review 2.  Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484).

Authors:  M L Molendijk; P Spinhoven; M Polak; B A A Bus; B W J H Penninx; B M Elzinga
Journal:  Mol Psychiatry       Date:  2013-08-20       Impact factor: 15.992

3.  The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive Symptoms.

Authors:  Warren Caldwell; Opal A McInnis; Robyn J McQuaid; Gele Liu; John D Stead; Hymie Anisman; Shawn Hayley
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

4.  Blood BDNF level is gender specific in severe depression.

Authors:  Anatoly Kreinin; Serah Lisson; Elimelech Nesher; Jenny Schneider; Josef Bergman; Kamal Farhat; Joseph Farah; Flavio Lejbkowicz; Gal Yadid; Leon Raskin; Igor Koman; Albert Pinhasov
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 5.  Cortisol and Major Depressive Disorder-Translating Findings From Humans to Animal Models and Back.

Authors:  L Sanjay Nandam; Matthew Brazel; Mei Zhou; Dhanisha J Jhaveri
Journal:  Front Psychiatry       Date:  2020-01-22       Impact factor: 4.157

6.  Mapping the structure of depression biomarker research: A bibliometric analysis.

Authors:  Xiang-Jie Guo; Peng Wu; Xiao Jia; Yi-Ming Dong; Chun-Mei Zhao; Nian-Nian Chen; Zhi-Yong Zhang; Yu-Ting Miao; Ke-Ming Yun; Cai-Rong Gao; Yan Ren
Journal:  Front Psychiatry       Date:  2022-09-16       Impact factor: 5.435

Review 7.  Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.

Authors:  Juan Joseph Young; Tim Silber; Davide Bruno; Isaac Robert Galatzer-Levy; Nunzio Pomara; Charles Raymond Marmar
Journal:  Front Psychiatry       Date:  2016-04-25       Impact factor: 4.157

8.  Increased Serum G Protein-coupled Estrogen Receptor 1 Levels and Its Diagnostic Value in Drug Naïve Patients with Major Depressive Disorder.

Authors:  Ebru Findikli; Ergül Belge Kurutas; Mehmet Akif Camkurt; Mehmet Fatih Karaaslan; Filiz Izci; Hüseyin Avni Fındıklı; Selçuk Kardaş; Berat Dag; Hatice Altun
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-11-30       Impact factor: 2.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.